Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia

Indeterminate cell histiocytosis (ICH) is a rare proliferative disorder, in which the predominant cells share morphologic and immunophenotypic features from both Langerhans and non-Langerhans cell histiocytosis. We describe a 62-year-old man presenting a 2-month history of firm nodular lesions on th...

Full description

Bibliographic Details
Main Authors: Filipa Ventura, Teresa Pereira, Maria da Luz Duarte, Herlander Marques, Fernando Pardal, Celeste Brito
Format: Article
Language:English
Published: Hindawi Limited 2010-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2010/569345
id doaj-864c2ccc413145c6b4f4bc308b290400
record_format Article
spelling doaj-864c2ccc413145c6b4f4bc308b2904002020-11-24T23:02:36ZengHindawi LimitedDermatology Research and Practice1687-61051687-61132010-01-01201010.1155/2010/569345569345Indeterminate Cell Histiocytosis in Association with Acute Myeloid LeukemiaFilipa Ventura0Teresa Pereira1Maria da Luz Duarte2Herlander Marques3Fernando Pardal4Celeste Brito5Dermatology and Venereology Department, Braga Hospital, Apartado 2242, 4701-965 Braga, PortugalDermatology and Venereology Department, Braga Hospital, Apartado 2242, 4701-965 Braga, PortugalDermatology and Venereology Department, Braga Hospital, Apartado 2242, 4701-965 Braga, PortugalOncology Department, Braga Hospital, 4701-965 Braga, PortugalPathology Department, Braga Hospital, 4701-965 Braga, PortugalDermatology and Venereology Department, Braga Hospital, Apartado 2242, 4701-965 Braga, PortugalIndeterminate cell histiocytosis (ICH) is a rare proliferative disorder, in which the predominant cells share morphologic and immunophenotypic features from both Langerhans and non-Langerhans cell histiocytosis. We describe a 62-year-old man presenting a 2-month history of firm nodular lesions on the upper lip. Histopathology, immunohistochemical, and ultrastructural analysis showed typical findings of ICH. The patient was treated with thalidomide and almost complete regression of the lesions was reached within 7 months. Nevertheless, one month after remission, he developed an acute myeloid leukemia of the subtype monocytic leukemia (M5). The patient's condition rapidly worsened and he died due to a respiratory failure four weeks later. We present this case because apart of being rare it joins the effectiveness of thalidomide and the association with an acute monocytic leukemia. A review of the literature is made.http://dx.doi.org/10.1155/2010/569345
collection DOAJ
language English
format Article
sources DOAJ
author Filipa Ventura
Teresa Pereira
Maria da Luz Duarte
Herlander Marques
Fernando Pardal
Celeste Brito
spellingShingle Filipa Ventura
Teresa Pereira
Maria da Luz Duarte
Herlander Marques
Fernando Pardal
Celeste Brito
Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia
Dermatology Research and Practice
author_facet Filipa Ventura
Teresa Pereira
Maria da Luz Duarte
Herlander Marques
Fernando Pardal
Celeste Brito
author_sort Filipa Ventura
title Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia
title_short Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia
title_full Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia
title_fullStr Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia
title_full_unstemmed Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia
title_sort indeterminate cell histiocytosis in association with acute myeloid leukemia
publisher Hindawi Limited
series Dermatology Research and Practice
issn 1687-6105
1687-6113
publishDate 2010-01-01
description Indeterminate cell histiocytosis (ICH) is a rare proliferative disorder, in which the predominant cells share morphologic and immunophenotypic features from both Langerhans and non-Langerhans cell histiocytosis. We describe a 62-year-old man presenting a 2-month history of firm nodular lesions on the upper lip. Histopathology, immunohistochemical, and ultrastructural analysis showed typical findings of ICH. The patient was treated with thalidomide and almost complete regression of the lesions was reached within 7 months. Nevertheless, one month after remission, he developed an acute myeloid leukemia of the subtype monocytic leukemia (M5). The patient's condition rapidly worsened and he died due to a respiratory failure four weeks later. We present this case because apart of being rare it joins the effectiveness of thalidomide and the association with an acute monocytic leukemia. A review of the literature is made.
url http://dx.doi.org/10.1155/2010/569345
work_keys_str_mv AT filipaventura indeterminatecellhistiocytosisinassociationwithacutemyeloidleukemia
AT teresapereira indeterminatecellhistiocytosisinassociationwithacutemyeloidleukemia
AT mariadaluzduarte indeterminatecellhistiocytosisinassociationwithacutemyeloidleukemia
AT herlandermarques indeterminatecellhistiocytosisinassociationwithacutemyeloidleukemia
AT fernandopardal indeterminatecellhistiocytosisinassociationwithacutemyeloidleukemia
AT celestebrito indeterminatecellhistiocytosisinassociationwithacutemyeloidleukemia
_version_ 1725635945242296320